BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of marker genes starting with is 95
| GENE | HGNC_ID | CANCER_TYPE | HISTOLOGICAL_TYPE | CSC_ENRICHMENT | METHOD | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|
| MYC | 7553 | Pancreatic Cancer | NA | NA | SFA and qRT-PCR followed by Western Blotting and IHC staining | 0.96 | 0.1304 | 26451606 |
| MYC | 7553 | Pancreatic Cancer | NA | NA | CFA followed by qRT-PCR | 0.96 | 0.1304 | 26199979 |
| MYC | 7553 | Pancreatic Cancer | NA | NA | qRT-PCR | 0.96 | 0.1304 | 21796625 |
| NANOG | 9221 | Pancreatic Cancer | NA | NA | SFA and qRT-PCR followed by Western Blotting and IHC staining | 0.96 | 0.5461 | 26451606 |
| NANOG | 20857 | Pancreatic Cancer | NA | NA | SFA followed by qRT-PCR and IF staining | 0.96 | 0.5461 | 26609473 |
| NANOG | 20857 | Pancreatic Cancer | NA | NA | IHC staining | 0.96 | 0.5461 | 23438436 |
| NANOG | 20857 | Pancreatic Cancer | NA | NA | CFA followed by qRT-PCR | 0.96 | 0.5461 | 26199979 |
| NANOG | 20857 | Pancreatic Cancer | NA | NA | qPCR followed by SFA | 0.96 | 0.5461 | 24785258 |
| NANOG | 20857 | Pancreatic Cancer | NA | NA | qRT-PCR | 0.96 | 0.5461 | 21796625 |
| POU5F1 | 7553 | Pancreatic Cancer | NA | NA | SFA and qRT-PCR followed by Western Blotting and IHC staining | 0.96 | 0.6448 | 26451606 |
| POU5F1 | 9221 | Pancreatic Cancer | NA | NA | SFA followed by qRT-PCR and IF staining | 0.96 | 0.6448 | 26609473 |
| POU5F1 | 9221 | Pancreatic Cancer | NA | NA | qPCR followed by SFA | 0.96 | 0.6448 | 24785258 |
| SOX2 | 11195 | Pancreatic Cancer | NA | NA | SFA and qRT-PCR followed by Western Blotting and IHC staining | 0.96 | 0.5695 | 26451606 |
| SOX2 | 11195 | Pancreatic Cancer | NA | NA | SFA followed by qRT-PCR and IF staining | 0.96 | 0.5695 | 26609473 |
| SOX2 | 11195 | Pancreatic Cancer | NA | NA | qPCR followed by SFA | 0.96 | 0.5695 | 24785258 |
| SOX2 | 11195 | Pancreatic Cancer | NA | NA | qRT-PCR | 0.96 | 0.5695 | 21796625 |
| GLI1 | 4317 | Pancreatic Cancer | NA | NA | qRT-PCR and Western Blotting | 0.64 | 0.0308 | 23029396 |
| GLI2 | 4318 | Pancreatic Cancer | NA | NA | qRT-PCR and Western Blotting | 0.64 | 0.0106 | 23029396 |
| GLI2 | 4318 | Pancreatic Cancer | NA | NA | CFA followed by qRT-PCR | 0.64 | 0.0106 | 26199979 |
| SATB2 | 1681 | Pancreatic Cancer | NA | NA | SFA followed by Western Blotting and qRT-PCR | 0.64 | 0.0021 | 27472393 |
| SMO | 11119 | Pancreatic Cancer | NA | NA | qRT-PCR and Western Blotting | 0.64 | 0.0212 | 23029396 |
| CD24 | 1645 | Pancreatic Cancer | NA | NA | CFA followed by qRT-PCR and ICC staining | 0.6 | 0.456 | 26199979 |
| CD24 | 1645 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining followed by FACs | 0.6 | 0.456 | 27414409 |
| CD24 | 1645 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.6 | 0.456 | 25240521 |
| CD24 | 1645 | Pancreatic Cancer | NA | NA | IHC staining | 0.6 | 0.456 | 25081383 |
| CD24 | 1645 | Pancreatic Cancer | NA | NA | FACs | 0.6 | 0.456 | 33188841 |
| CD24 | 1645 | Pancreatic Cancer | NA | NA | FACs | 0.6 | 0.456 | 23029396 |
| CD24 | 1645 | Pancreatic Cancer | Adenocarcinoma | NA | FACs | 0.6 | 0.456 | 30074477 |
| CD24 | 1645 | Pancreatic Cancer | Adenocarcinoma | NA | FACs followed by Tumorigenicity assay | 0.6 | 0.456 | 17283135 |
| CD24 | 1645 | Pancreatic Cancer | Adenocarcinoma | NA | SP assay followed by FACs | 0.6 | 0.456 | 32132023 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | CFA followed by qRT-PCR and ICC staining | 0.6 | 1 | 26199979 |
| CD44 | 1681 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining followed by FACs | 0.6 | 1 | 27414409 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | MACs followed by SFA and qRT-PCR | 0.6 | 1 | 26609473 |
| CD44 | 1681 | Pancreatic Cancer | Ductal Adenocarcinoma | NA | IHC staining | 0.6 | 1 | 33836674 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | IHC staining | 0.6 | 1 | 33672734 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | IHC staining | 0.6 | 1 | 19598259 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | IHC staining | 0.6 | 1 | 22783415 |
| CD44 | 1681 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.6 | 1 | 25240521 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | IHC staining | 0.6 | 1 | 24839953 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | IHC staining | 0.6 | 1 | 25081383 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | FACs | 0.6 | 1 | 33188841 |
| CD44 | 1681 | Pancreatic Cancer | NA | NA | FACs | 0.6 | 1 | 23029396 |
| CD44 | 1681 | Pancreatic Cancer | Adenocarcinoma | NA | FACs | 0.6 | 1 | 30074477 |
| CD44 | 1681 | Pancreatic Cancer | Adenocarcinoma | NA | FACs followed by Tumorigenicity assay | 0.6 | 1 | 17283135 |
| CD44 | 1681 | Pancreatic Cancer | Ductal Adenocarcinoma | NA | SFA followed by FACs | 0.6 | 1 | 33240436 |
| CTSB | 2527 | Pancreatic Cancer | Ductal Adenocarcinoma | NA | SFA followed by Western Blotting and FACs | 0.56 | 0.0053 | 33240436 |
| ALDH1A1 | 402 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining followed by FACs | 0.52 | 0.684 | 21695188 |
| ALDH1A1 | 402 | Pancreatic Cancer | NA | NA | IF staining | 0.52 | 0.684 | 33110235 |
| ALDH1A1 | 402 | Pancreatic Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 33672734 |
| ALDH1A1 | 402 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.684 | 21922151 |
| ALDH1A1 | 402 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.684 | 25240521 |
| ALDH1A1 | 402 | Pancreatic Cancer | Adenocarcinoma | NA | ALDEFLUOR assay followed by SFA | 0.52 | 0.684 | 26691441 |
| EPCAM | 11529 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining followed by FACs | 0.52 | 0.211 | 27414409 |
| EPCAM | 11529 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.211 | 25240521 |
| EPCAM | 11529 | Pancreatic Cancer | NA | NA | FACs | 0.52 | 0.211 | 23029396 |
| EPCAM | 11529 | Pancreatic Cancer | Adenocarcinoma | NA | FACs followed by Tumorigenicity assay | 0.52 | 0.211 | 17283135 |
| EPCAM | 11529 | Pancreatic Cancer | Ductal Adenocarcinoma | NA | IHC staining | 0.52 | 0.211 | 33836674 |
| EPCAM | 11529 | Pancreatic Cancer | NA | NA | FACs | 0.52 | 0.211 | 33188841 |
| EPCAM | 11529 | Pancreatic Cancer | Adenocarcinoma | NA | SP assay followed by FACs | 0.52 | 0.211 | 32132023 |
| PROM1 | 9454 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining followed by FACs | 0.52 | 0.7582 | 27414409 |
| PROM1 | 9454 | Pancreatic Cancer | Carcinoma | NA | IHC staining | 0.52 | 0.7582 | 18349830 |
| PROM1 | 9454 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.7582 | 21922151 |
| PROM1 | 9454 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.7582 | 25240521 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | IHC staining | 0.52 | 0.7582 | 26840020 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | IHC staining | 0.52 | 0.7582 | 32197003 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | IHC staining | 0.52 | 0.7582 | 24839953 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | IHC staining | 0.52 | 0.7582 | 25081383 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | SFA followed by qRT-PCR | 0.52 | 0.7582 | 26609473 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | FACs | 0.52 | 0.7582 | 20564084 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | FACs | 0.52 | 0.7582 | 23029396 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | IHC staining | 0.52 | 0.7582 | 33672734 |
| PROM1 | 9454 | Pancreatic Cancer | NA | NA | FACs followed by SFA | 0.52 | 0.7582 | 33067432 |
| LIN28B | 32207 | Pancreatic Cancer | NA | NA | MACs followed by SFA and qRT-PCR | 0.48 | 0.0032 | 26609473 |
| ABCB1 | 40 | Pancreatic Cancer | NA | NA | IF staining | 0.32 | 0.0604 | 33110235 |
| ABCB1 | 40 | Pancreatic Cancer | Adenocarcinoma | NA | SP assay followed by IHC staining | 0.32 | 0.0604 | 24069258 |
| ABCG2 | 74 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.1739 | 21922151 |
| ABCG2 | 74 | Pancreatic Cancer | NA | NA | SFA followed by qRT-PCR | 0.32 | 0.1739 | 26609473 |
| ABCG2 | 74 | Pancreatic Cancer | NA | NA | FACs | 0.32 | 0.1739 | 23029396 |
| BMI1 | 1066 | Pancreatic Cancer | NA | NA | IHC staining | 0.32 | 0.1135 | 26840020 |
| CXCR1 | 6026 | Pancreatic Cancer | NA | NA | IHC staining | 0.32 | 0.0032 | 25081383 |
| CXCR4 | 2561 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.0498 | 25240521 |
| GLRX3 | 15987 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.0032 | 34794402 |
| JAG1 | 6188 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.0117 | 21922151 |
| JAG2 | 6189 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.0032 | 21922151 |
| LGR5 | 4504 | Pancreatic Cancer | NA | NA | IHC staining | 0.32 | 0.0753 | 23438436 |
| LGR5 | 4504 | Pancreatic Cancer | NA | NA | IHC staining | 0.32 | 0.0753 | 35123536 |
| NES | 7756 | Pancreatic Cancer | NA | NA | IHC staining | 0.32 | 0.0573 | 32197003 |
| NOTCH1 | 7881 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.0477 | 21922151 |
| NOTCH2 | 7882 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.0117 | 21922151 |
| NOTCH3 | 7883 | Pancreatic Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.0085 | 21922151 |
| SNAI2 | 11094 | Pancreatic Cancer | NA | NA | SFA followed by IHC staining | 0.32 | 0.0159 | 34628696 |
| KIT | 6342 | Pancreatic Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.018 | 26609473 |
| SNAI1 | 11128 | Pancreatic Cancer | NA | NA | qPCR followed by SFA | 0.28 | 0.0212 | 24785258 |
| TERT | 11730 | Pancreatic Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0053 | 26609473 |
| TNFRSF4 | 11918 | Pancreatic Cancer | NA | NA | FACs followed by Tumorigenicity assay | 0.2 | 0.0021 | 18371365 |